Shyam Prabhakaran1, Margueritte Cox1, Barbara Lytle1, Phillip J Schulte1, Ying Xian1, Darin Zahuranec1, Eric E Smith1, Mathew Reeves1, Gregg C Fonarow1, Lee H Schwamm1. 1. Feinberg School of Medicine (SP), Northwestern University, Chicago, IL; Duke Clinical Research Institute (MC, BL, PJS, YX), Durham, NC; University of Michigan (DZ), Ann Arbor; Hotchkiss Brain Institute (EES), University of Calgary, Canada; Michigan State University (MR), East Lansing; Ahmanson Cardiomyopathy Center (GCF), UCLA, Los Angeles, CA; Stroke Service (LHS), Massachusetts General Hospital, Boston; and Duke University Medical Center (YX), Durham, NC.
Abstract
BACKGROUND: Death after acute stroke often occurs after forgoing life-sustaining interventions. We sought to determine the patient and hospital characteristics associated with an early decision to transition to comfort measures only (CMO) after ischemic stroke (IS), intracerebral hemorrhage (ICH), and subarachnoid hemorrhage (SAH) in the Get With The Guidelines-Stroke registry. METHODS: We identified patients with IS, ICH, or SAH between November 2009 and September 2013 who met study criteria. Early CMO was defined as the withdrawal of life-sustaining treatments and interventions by hospital day 0 or 1. Using multivariable logistic regression, we identified patient and hospital factors associated with an early (by hospital day 0 or 1) CMO order. RESULTS: Among 963,525 patients from 1,675 hospitals, 54,794 (5.6%) had an early CMO order (IS: 3.0%; ICH: 19.4%; SAH: 13.1%). Early CMO use varied widely by hospital (range 0.6%-37.6% overall) and declined over time (from 6.1% in 2009 to 5.4% in 2013; p < 0.001). In multivariable analysis, older age, female sex, white race, Medicaid and self-pay/no insurance, arrival by ambulance, arrival off-hours, baseline nonambulatory status, and stroke type were independently associated with early CMO use (vs no early CMO). The correlation between hospital-level risk-adjusted mortality and the use of early CMO was stronger for SAH (r = 0.52) and ICH (r = 0.50) than AIS (r = 0.15) patients. CONCLUSIONS: Early CMO was utilized in about 5% of stroke patients, being more common in ICH and SAH than IS. Early CMO use varies widely between hospitals and is influenced by patient and hospital characteristics.
BACKGROUND: Death after acute stroke often occurs after forgoing life-sustaining interventions. We sought to determine the patient and hospital characteristics associated with an early decision to transition to comfort measures only (CMO) after ischemic stroke (IS), intracerebral hemorrhage (ICH), and subarachnoid hemorrhage (SAH) in the Get With The Guidelines-Stroke registry. METHODS: We identified patients with IS, ICH, or SAH between November 2009 and September 2013 who met study criteria. Early CMO was defined as the withdrawal of life-sustaining treatments and interventions by hospital day 0 or 1. Using multivariable logistic regression, we identified patient and hospital factors associated with an early (by hospital day 0 or 1) CMO order. RESULTS: Among 963,525 patients from 1,675 hospitals, 54,794 (5.6%) had an early CMO order (IS: 3.0%; ICH: 19.4%; SAH: 13.1%). Early CMO use varied widely by hospital (range 0.6%-37.6% overall) and declined over time (from 6.1% in 2009 to 5.4% in 2013; p < 0.001). In multivariable analysis, older age, female sex, white race, Medicaid and self-pay/no insurance, arrival by ambulance, arrival off-hours, baseline nonambulatory status, and stroke type were independently associated with early CMO use (vs no early CMO). The correlation between hospital-level risk-adjusted mortality and the use of early CMO was stronger for SAH (r = 0.52) and ICH (r = 0.50) than AIS (r = 0.15) patients. CONCLUSIONS: Early CMO was utilized in about 5% of strokepatients, being more common in ICH and SAH than IS. Early CMO use varies widely between hospitals and is influenced by patient and hospital characteristics.
Authors: Albert J Yoo; Zeshan A Chaudhry; Raul G Nogueira; Michael H Lev; Pamela W Schaefer; Lee H Schwamm; Joshua A Hirsch; R Gilberto González Journal: Stroke Date: 2012-03-15 Impact factor: 7.914
Authors: Harlan M Krumholz; Zhenqiu Lin; Elizabeth E Drye; Mayur M Desai; Lein F Han; Michael T Rapp; Jennifer A Mattera; Sharon-Lise T Normand Journal: Circ Cardiovasc Qual Outcomes Date: 2011-03
Authors: Vivien H Lee; Bichun Ouyang; Sayona John; James J Conners; Rajeev Garg; Thomas P Bleck; Richard E Temes; Shawna Cutting; Shyam Prabhakaran Journal: Neurocrit Care Date: 2014-08 Impact factor: 3.210
Authors: Ying Xian; Robert G Holloway; Eric E Smith; Lee H Schwamm; Mathew J Reeves; Deepak L Bhatt; Phillip J Schulte; Margueritte Cox; DaiWai M Olson; Adrian F Hernandez; Barbara L Lytle; Kevin J Anstrom; Gregg C Fonarow; Eric D Peterson Journal: Stroke Date: 2014-09-11 Impact factor: 7.914
Authors: Eric Racine; Marie-Josée Dion; Christine A C Wijman; Judy Illes; Maarten G Lansberg Journal: Neurocrit Care Date: 2009-12 Impact factor: 3.210
Authors: Eric E Smith; Nandavar Shobha; David Dai; DaiWai M Olson; Mathew J Reeves; Jeffrey L Saver; Adrian F Hernandez; Eric D Peterson; Gregg C Fonarow; Lee H Schwamm Journal: J Am Heart Assoc Date: 2013-01-28 Impact factor: 5.501
Authors: Claire J Creutzfeldt; Benzi Kluger; Adam G Kelly; Monica Lemmon; David Y Hwang; Nicholas B Galifianakis; Alan Carver; Maya Katz; J Randall Curtis; Robert G Holloway Journal: Neurology Date: 2018-06-27 Impact factor: 9.910
Authors: Chun Mei Su; Andrew Warren; Cassie Kraus; Wendy Macias-Konstantopoulos; Kori S Zachrison; Anand Viswanathan; Christopher Anderson; M Edip Gurol; Steven M Greenberg; Joshua N Goldstein Journal: Int J Emerg Med Date: 2021-01-19